The approved product is therapeutically equivalent to Boehringer Ingelheim Pharmaceuticals Inc's Pradaxa Capsules (110 mg) and are re indicated for prophylaxis of deep vein thrombosis and pulmonary embolism following hip replacement surgery.
from Health News | Latest Healthcare Sector & Healthcare Industry news, Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/qwtOvWc
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment